WHO advisers recommend changes in Ebola vaccine strategy

WHO advisers recommend changes in Ebola vaccine strategy
The changes include cutting the dose of the existing Merck vaccine, expanding the population eligible for vaccination, introducing targeted geographic vaccination where appropriate, and introducing a second experimental vaccine developed by Johnson & Johnson. Image Credit: Twitter(@As_SyIFRC)
  • Country:
  • Congo
  • Congo Dem Rep

The World Health Organization's strategic advisory group (SAGE) of vaccine experts have recommended speeding up vaccinations to tackle the Ebola outbreak in Democratic Republic of Congo, the WHO said on Tuesday.

The changes include cutting the dose of the existing Merck vaccine, expanding the population eligible for vaccination, introducing targeted geographic vaccination where appropriate, and introducing a second experimental vaccine developed by Johnson & Johnson.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.